Gene Query: ARRDC3

Dataset Description Geneva Score
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 147.71
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 122.88
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 103.64
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 101.83
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 96.25
RNA-sequencing of human liver tissue 94.24
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 93.98
Hypoxic transcriptome of SQ20B human head and neck cancer cells 85.92
LncRNA-GAS5 negative regulation of YAP-target genes expression 85.0
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 83.79
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 76.35
RNA-seq of young and quiescent MRC-5 human fibroblasts 74.7
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 71.28
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 71.23
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 68.06
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 68.06
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 67.93
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 67.5
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 67.4
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 67.4
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 63.65
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 63.15
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 60.45
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 56.52
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 56.37
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 55.53
The regulartory role of ZCCHC24 in splicing machinery 54.66
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 52.82
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 52.45
A sister of NANOG regulates genes expressed in pre-implantation human development 51.45
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 51.2
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 51.04
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 50.99
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 50.99
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 50.93
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 50.55
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 50.32
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 47.62
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 47.21
Ebola virus (EBOV) infection of ARPE-19 cells 43.55
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 43.49
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 42.3
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 40.53
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 39.61
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 39.51
Silencing SPIB in attached and floating state of H1703 lung cancer cells 39.2
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 37.81
RNA sequencing of GlyH-101-treated MCF-7 cell line 36.62
Landscape of H3K4me3 in human CD19 cells 36.19
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 36.04
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 35.98
Endothelial gene expression analysis 35.98
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 35.85
Genetic-to-epigenetic Therapy for Pancreatic Cancer 35.71
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 35.59
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 35.44
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 35.34
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 35.34
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 34.94
HNF1 regulates critical functions of the human epididymis epithelium. 34.81
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 34.81
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 34.38
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 34.29
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 34.26
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 34.12
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 34.12
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 33.48
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 33.31
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 33.09
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 33.09
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 32.67
Gene expression analysis of dengue-infected cells 32.66
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 32.52
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 32.52
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 32.36
Irf9 function in immunity in mouse 32.36
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 32.08
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 31.94
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 31.86
Paxillin regulates genomic networks in prostate cancer [PC3] 31.81
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 31.78
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 31.58
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 31.21
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 30.48
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 30.48
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 29.82
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 29.74
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 29.74
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 29.73
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 29.64
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 29.56
SNHG5 siRNA knock down in HCT116 cells 29.42
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 29.13
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 29.02
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 28.98
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 28.93
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 28.85
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 28.72
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 28.36
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 28.23
RNA-seq of shEZH2 cells 28.2
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 28.17
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 27.78
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 27.62
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 27.45
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 27.44
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 27.36
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 27.02
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 26.9
A549 cell transcriptome responses to infection with H7N9 influenza virus 26.54
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  26.26
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 26.21
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 26.02
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 26.02
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 25.89
Human Treg NaCl stimulation 25.72
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 25.4
Selective suppression of endothelial cytokine production by progesterone receptor 25.4
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 25.34
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 25.29
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 25.29
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 25.03
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 24.98
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 24.92
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 24.76
Transcriptomic profiling of human peripheral blood-derived mast cells 24.75
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 24.75
Gene expression profile of human iPSC-derived nephron progenitor cells 24.64
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 24.6
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 24.35
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 24.35
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 24.24
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 24.24
BAF controls genome accessibility 24.19
Regulation of hypoxia-inducible factor activity by ZMYND8 24.14
Inhibition of TNBC metastasis by Gpx1 24.05
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 24.02
4sU-seq of HFF exposed to salt and heat stress 23.98
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 23.76
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 23.6
RNA-seq of naive and primed ES cells (NHSM) 23.56
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 23.49
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 23.48
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 23.0
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 22.97
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 22.92
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 22.61
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 22.61
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 22.55
JunB control of keratinocyte-mediated inflammation [RNA-seq] 22.55
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 22.5
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 22.49
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 22.41
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 22.27
RNA-seq analysis of RALD iPSCs after in vitro differentiation 22.1
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 22.0
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 21.76
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 21.61
Zone dependent distinctive gene expression profile of the normal human liver tissue 21.47
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 21.45
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 21.44
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 21.3
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 21.19
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 21.19
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 21.14
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 21.12
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 20.85
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 20.74
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 20.74
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 20.73
TFAP2C signalling in human fibroblasts 20.72
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 20.33
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 20.2
Region-specific Innate Antiviral Responses of the Human Epididymis 20.01
ARID1A regulates condensin II distribution and chromosomal partition 19.95
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 19.95
Expression level comparison under dividing and quiescent states in human primary fibroblasts 19.84
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 19.82
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 19.82
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 19.82
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 19.8
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 19.8
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 19.79
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 19.77
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 19.64
Examining serotonergic neuron differentiation from human iPSCs 19.64
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 19.63
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 19.59
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 19.35
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 19.3
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 19.21
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 19.17
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 19.15
RNA-seq of resting and activated CD4+ T cells +-JQ1 19.15
TCF7L1 knockdown in pancreatic cancer 19.11
Human HAP1 cells before and after nutrient deprivation 19.08
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 19.08
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 19.08
A549 cells and MSR-A549 cells 19.06
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 19.06
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 19.04
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 19.02
Differential analysis of gene regulation at transcript resolution by RNA-Seq 19.02
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 19.02
UBC9 knockdown in bladder cancer T24 cell lines 18.9
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 18.84
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 18.63
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 18.6
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 18.59
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 18.5
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 18.49
Pharmacologic inhibition of STAT5 in AML 18.48
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 18.28
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 18.28
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 18.25
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 18.23
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 18.21
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 18.21
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 18.2
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 18.18
Identification of global XBP1s target gene expression in human prostate cancer cells 18.15
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 18.08
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 18.01
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 18.01
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 17.97
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 17.97
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 17.91
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 17.91
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 17.91
Paxillin regulates genomic networks in prostate cancer [LNCaP] 17.82
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 17.77
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 17.77
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 17.62
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 17.62
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 17.6
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 17.57
RNA sequencing analysis of human embryonic stem cells and axial progenitors 17.5
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 17.45
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 17.45
Oncogenic MYC induces a dependency on the spliceosome in human cancer 17.41
Transcriptome of activated human and mouse MAIT cells 17.38
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 17.36
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 17.35
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 17.33
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 17.27
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 17.27
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 17.24
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 17.15
Human neutrophil genome during PMA- and E. coli encounter-induced activation 17.15
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 17.1
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 17.08
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 17.02
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 17.01
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 17.01
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 16.87
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 16.78
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 16.75
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 16.7
Effect of from Human Umbilical Vein Endothelial Cells 16.65
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 16.52
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 16.48
Genome-wide functional assessment of enhancer activities in the human genome 16.47
Human Treg IL-12 stimulation 16.45
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 16.38
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 16.37
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 16.33
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 16.33
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 16.3
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 16.16
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 16.0
Androgen Receptor-regulated genes in prostate cancer cells 16.0
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 15.86
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 15.69
Gene expressions of H9s in different culture systems 15.69
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 15.68
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 15.63
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 15.59
Generation and functional characterization of MDSC-like cells 15.51
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 15.49
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 15.38
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 15.38
The effect of insulin on mRNA transcription of human pluripotent stem cells 15.36
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 15.27
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 15.05
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 15.01
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 15.0
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 14.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 14.98
mRNA-Seq profiling of human developing kidney 14.82
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 14.8
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 14.77
TAF1 is critical for AE driven leukemogenesis 14.77
RNA-Seq with and without RNase treatment in PCa cell lines 14.74
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 14.7
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 14.62
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 14.39
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 14.32
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 14.27
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 14.26
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 14.14
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 13.99
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 13.93
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 13.93
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 13.88
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 13.81
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 13.8
ARID1A and ARID1B loss in HCT116 and TOV21G cells 13.79
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 13.64
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 13.56
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 13.46
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 13.38
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 13.33
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 13.12
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 13.11
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 13.07
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 13.07
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 13.06
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 12.99
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 12.99
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 12.99
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 12.89
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 12.85
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 12.85
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 12.85
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 12.75
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 12.61
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 12.59
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 12.52
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 12.41
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 12.4
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 12.39
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 12.38
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 12.37
STX4 Over-Expression in Human islets 12.29
Transcriptome Profiling of Human Primary Monocytes 12.14
UV_24h_GRO-Seq 11.74
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 11.73
The role of CFTR in islet function 11.64
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 11.22
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 11.22
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 11.04
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 11.0
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 10.86
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 10.82
RNA sequencing of matched nephrectomy samples [RNA-seq] 10.82
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 10.78
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 10.78
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 10.74
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 10.72
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 10.67
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 10.58
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 10.54
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 10.44
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 10.41
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 10.41
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 10.4
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 10.36
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 10.21
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 10.07
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 10.06
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 10.01
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 9.95
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 9.95
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 9.95
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 9.89
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 9.74
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 9.68
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 9.68
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 9.63
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 9.52
RNAseq analysis of ESRP regulated splicing events in prostate cancer 9.36
4sUDRB-seq: measuring transcription elongation and initiation genomewide 9.28
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 9.22
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 9.22
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 9.16
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 9.06
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 9.05
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 8.95
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.93
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 8.93
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 8.89
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 8.81
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 8.56
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 8.49
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 8.43
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.4
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 8.26
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 8.23
Anti-inflammatory effect of indoleacrylic acid (IA) 8.23
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 8.21
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 8.12
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 7.96
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 7.95
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 7.92
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 7.67
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 7.6
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 7.6
oxLDL exposed trained monocytes 7.58
Transcriptomes of oxLDL exposed trained monocytes 7.58
Random mono-allelic expression in MECP2-mutated cells 7.49
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.49
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 7.47
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 7.35
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 7.33
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.16
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 6.96
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 6.96
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 6.88
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 6.86
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 6.85
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 6.76
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 6.66
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 6.64
RNA seq analysis of human Fetal and adult derived Enterospheres 6.64
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 6.55
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 6.48
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 6.48
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 6.11
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.08
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 6.08
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 5.84
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 5.81
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 5.78
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 5.78
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 5.59
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.58
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.58
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 5.57
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 5.53
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.46
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 5.36
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.26
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 5.2
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 5.2
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 5.16
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 5.14
RNA-sequencing of healthy human skeletal myocytes 4.58
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 4.55
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 4.52
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.45
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.43
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.42
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 4.4
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 4.4
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.37
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 4.36
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.2
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 4.2
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 4.15
Alagille_Nodder 4.03
RNA Seq of Alagille liver biopsies 4.03
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 3.92
Transcriptome analysis of CNS leukemia 3.88
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.88
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.67
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.67
Clinker: visualizing fusion genes detected in RNA-seq data 3.66
The transcriptome of Kawasaki Disease arteritis 3.54
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.48
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.47
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 3.42
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 3.42
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.33
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.98
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.89
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 2.84
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.74
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.62
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 2.48
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.42
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.42
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.3
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 2.16
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.11
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.11
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 2.04
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 1.87
Identification of renal resident macrophages across species [C1] 1.72
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.64
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.61
6mer seed toxicity in viral microRNAs 1.56
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.44
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.44
Modeling Human Cancer-induced Cachexia (Human) 1.19
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.15
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.1
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.03
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.0
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.92
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.87
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.82
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.79
High-resolution comparative analysis of great ape genomes 0.61
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.54
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.31
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.05
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.05
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation